Hernández-Ronquillo L, Téllez-Zenteno JF, Garduño-Espinosa J, González-Acevez E

Language: English
References: 27
Page: 191-197
PDF size: 62.95 Kb.

ABSTRACT

Objective. To identify the frequency and factors associated with therapy noncompliance in type-2 diabetes mellitus patients. Material and Methods. A cross-sectional study was carried out in 79 patients with type-2 diabetes mellitus seen in major hospitals of Mexico City. Patients were visited at home, from March 1998 to August 1999, to measure compliance with prescribed therapy. Complying patients were defined as those taking at least 80% of their pills or 80% of their corresponding insulin dose. The degree of compliance with therapy components (diet, amount of exercise, and keeping appointments) was measured. Results. The average age of study subjects was 59 years (SD 11 years); 73% (n=58) were female subjects. The overall frequency of noncompliance was 39%. Noncompliance rates were: 62% for dietary recommendations, 85% for exercise, 17% for intake of oral hypoglycemic medication, 13% for insulin application, and 3% for appointment keeping. Hypertension plus obesity was the only factor significantly associated with noncompliance (OR 4.58, CI 95% 1.0, 22.4, p=0.02). Conclusions. The frequency of therapy noncompliance was very high, especially for diet and exercise.

REFERENCES

1. Martínez C, Guiscafré H, Muñoz O, Gutiérrez G. Análisis del incumplimiento del tratamiento con los esquemas terapéuticos utilizados. Arch Invest Med 1988;9:409-417.

2. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxina. Arch Intern Med 1979;139:635-638.

3. Rudd P. In search of the gold standard for compliance measurement. Arch Intern Med 1979;139:627-628.

4. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Diabetes Care 1996;19:l154-1164.

5. Watkins JD, Williams F, Martin DA, Hogan MD, Anderson E. A study of diabetic patients at home. J Am Public Health 1967;56:452-459.

6. Cerkoney AB, Hart K. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care 1980;3:594-598.

7. Morrison EY, Bennett F. Assessment of patient compliance in a diabetic clinic using glycated proteins compared with blood sugar measurements. West Indian Med J 1988;37:58-61.

8. Irwin M, Rosenstock IM. Understanding and enhancing patient compliance with diabetic regimes. Diabetes Care 1985;8:610-616.

9. Nagasawa M, Smith MC, Barnes JH, Fincham JE. Meta-analysis of correlates of diabetes patients’ compliance with prescribed medications. Diabetes Educ 1990;16:192-200.

10. Rull JA, Ríos JM, Gómez-Pérez FJ, Olaiz G, Tapia R, Sepúlveda J. The impact of diabetes mellitus on public health in Mexico. En: Schwartz C, Born G. New horizons in diabetes mellitus and cardiovascular disease. Curr Sci 1998;1:64-74.

11. Suárez-Mendoza A, Cardiel M, Caballero-Uribe C, Ortega-Soto H, Márquez-Marín M. Measurement of depression in Mexican patients with rheumatoid arthritis: Validity of the Beck Depression Inventory. J Rheumatol 1997;10:194-199.

12. Torres-Castillo M, Hernández-Malpica E, Ortega-Soto HA. Validez y reproducibilidad del inventario para depresión de beck en un hospital de cardiología. Salud Mental 1991;14:1-6.

13. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G. La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med 1988;19:351-360.

14. Beck AT, Ward CH, Mendelsson A. An Inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.

15. Venter HL, Joubert PH, Foukaridis GN. Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy. S Afr Med J 1991;79:549-551.

16. Harris R, Linn M. Health beliefs, compliance, and control of diabetes mellitus. South Med J 1985;78:162-166.

17. Diehl AK, Bauer RL, Sugarek NJ. Correlates of medication compliance in non-insulin-dependent diabetes mellitus. South Med J 1987;80:332-335.

18. Kravitz RL, Hays RD, Sherbourne CD, DiMatteo, Rogers WH, Ordway L et al. Recall to recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993; 16: 1869-1878.

19. Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: Patient, doctor, practice or delivery of care? Br Med J 1993;306:630-634.

20. O’Connor PJ, Fragneto R, Coulehan J, Crabtree BF. Metabolic control in non-insulin-dependent diabetes mellitus: Factors associated with patient outcomes. Diabetes Care 1987; 10: 697-701.

21. Wing RR, Epstein LH, Nowalk MP, Scott N, Koeske R, Hagg S. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes? Am J Med 1986;81:830-836.

22. Bundo-Vidiella M, Auba-Llambrich J, Massons-Cirera J, Trilla-Soler MC, Pérez-Villegas R, Pérez-del Campo AM. Ansiedad y depresión en pacientes diabéticos tipo II. Aten Primaria 1996;17:58-62.

23. House W, Pendleton L, Parker L. Patients’ Versus physicians’ attributions of reasons for diabetic patients’ noncompliance with diet. Diabetes Care 1986;9:434.

24. Schlundt DG, Rea MR, Kline S, Pichert JW. Situational obstacles to dietary adherence for adults with diabetes. J Am Diet Assoc 1994;8:874-879.

25. Schneider SH, Johnson RW, Ruderman NB. Exercise and DIDDM. Diabetes Care 1990;13:785-789.

26. Kamiya A, Osawa I, Fujii T, Nagai M, Yamanouchi K, Oshida Y et al. A clinical survey of the compliance of exercise therapy for diabeticoutpatients. Diabetes Res Clin Pract 1995;27:141-145.

27. Khoza SR, Kortenbout W. An investigation of compliance in type II diabetic patients attending clinic at Church of Scotland Hospital. Curationis 1995;18:10-14.